| AI | Artificial Intelligence. |
| ANOVA | Analysis of Variance. |
| ASC-H | Atypical Squamous Cells That Cannot Exclude High-Grade Squamous Intraepithelial Lesion. |
| ASC-US | Atypical Squamous Cells of Undetermined Significance. |
| ASCCP | American Society for Colposcopy and Cervical Pathology. |
| CDC | Centers for Disease Control and Prevention. |
| CI | Confidence Interval. |
| CIN | Cervical Intraepithelial Neoplasia. |
| CIN2+ | Cervical Intraepithelial Neoplasia grade 2 or worse. |
| CIN3+ | Cervical Intraepithelial Neoplasia grade 3 or carcinoma in situ. |
| CIS | Carcinoma in Situ. |
| COC | Combined Oral Contraceptives. |
| EU/EEA | European Union / European Economic Area. |
| HGSIL | High-Grade Squamous Intraepithelial Lesion. |
| HPV | Human Papillomavirus. |
| hrHPV | High-Risk Human Papillomavirus. |
| HSIL | High-Grade Squamous Intraepithelial Lesion. |
| HTN | Hypertension. |
| KPNC | Kaiser Permanente Northern California. |
| LGSIL | Low-Grade Squamous Intraepithelial Lesion. |
| LLETZ | Large Loop Excision of the Transformation Zone. |
| LSIL | Low-Grade Squamous Intraepithelial Lesion. |
| NBCCEDP | National Breast and Cervical Cancer Early Detection Program. |
| NILM | Negative for Intraepithelial Lesion or Malignancy. |
| PB | Punch Biopsy. |
| p16/Ki67 | (Dual immunohistochemical) p16 and Ki-67 proteins. |
| SCC | Squamous Cell Carcinoma. |
| SD | Standard Deviation. |
| SHR | Subdistribution Hazard Ratio. |
| STI | Sexually Transmitted Infection. |
| WHO | World Health Organization. |